Israel - English - Ministry of Health

devries & co. ltd - oxerutines - capsules - oxerutines 300 mg - monoxerutin - monoxerutin - for the adjunctive treatment of varicose veins in all stages.

Israel - English - Ministry of Health

devries & co. ltd - guaifenesin - syrup - guaifenesin 100 mg / 5 ml - guaifenesin - guaifenesin - expectorant, relieves cough.

Israel - English - Ministry of Health

devries & co. ltd - ketoconazole - cream - ketoconazole 20 mg/g - ketoconazole - ketoconazole - for topical application in the treatment of dermatophyte infections of the skin such as tinea corporis, tinea cruris, tinea manus and tinea pedis infections due to trichophyton spp, microsporon spp and epidermophyton spp. nizoral cream is also indicated for the treatment of cutaneous candidosis (including vulvitis), tinea (pityriasis) versicolor and seborrhoeic dermatitis caused by malassezia (previously called pityrosporum) spp.

Israel - English - Ministry of Health

devries & co. ltd - cetrimonium bromide; lidocaine; tyrothricin - lozenges - lidocaine 1 mg; tyrothricin 4 mg; cetrimonium bromide 2 mg - lidocaine - lidocaine - for the relief of pain associated with severe sore throat and mouth infections.

Israel - English - Ministry of Health

devries & co. ltd - cetrimonium bromide; lidocaine; tyrothricin - lozenges - lidocaine 1 mg; tyrothricin 4 mg; cetrimonium bromide 2 mg - lidocaine - for the relief of pain associated with severe sore throat and mouth infections.

European Union - English - EMA (European Medicines Agency)

stada arzneimittel ag - budesonide, micronised - glomerulonephritis, iga - antidiarrheals, intestinal antiinflammatory / antiinfective agents - kinpeygo is indicated for the treatment of primary immunoglobulin a (iga) nephropathy (igan) in adults at risk of rapid disease progression with a urine protein-to-creatinine ratio (upcr) ≥1.5 g/gram.

European Union - English - EMA (European Medicines Agency)

stada arzneimittel ag - teriparatide - osteoporosis - calcium homeostasis - movymia is indicated in adults.treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture. in postmenopausal women, a significant reduction in the incidence of vertebral and non vertebral fractures but not hip fractures has been demonstrated.treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture.

European Union - English - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologicals - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv)